Latest Listings And Ipos News

Osteopore Limited has secured an exclusive multi-year distribution agreement with Majeton to commercialise its dental and maxillofacial products in China, Hong Kong, and Macau, marking a major step in its Asia-Pacific expansion.

Lunnon Metals has completed a detailed Feasibility Study for its Lady Herial gold deposit, outlining a robust, short-life open pit mine with strong pre-tax cash flows exceeding $40 million. The project is fully permitted and poised for imminent development.

Eastern Metals Limited has responded to ASX concerns over delayed disclosure of director interest changes, attributing the lapse to end-of-year administrative challenges while affirming its compliance framework remains robust.

Findi Limited has landed a significant pre-IPO investment from Nova Global Opportunities Fund PCC, setting the stage for its Indian subsidiary’s planned listing on the Bombay Stock Exchange by FY27. This deal supports a Findi share price target between $5.58 and $6.69.

Beacon Minerals reported a solid December quarter with 7,310 ounces of gold produced and a 23% rise in realised gold prices, driving revenue to $53.47 million. The company is transitioning mining operations while maintaining strong recovery rates and shareholder returns.

BlackRock Investment Management (Australia) Limited has announced the Distribution Reinvestment Plan (DRP) prices for several Australian-domiciled iShares ETFs for the December 2025 distribution period, providing key details for investors opting into reinvestment.

Tasman Resources has clarified the reasons behind its recent share price jump, pointing to a significant new investor, upcoming drilling programs, and a rising stake in Eden Innovations. The company reassures the market it remains fully compliant with ASX disclosure rules.

Accent Resources NL has withdrawn a previously stated production target for its Magnetite Range Project, clarifying the figure was aspirational and non-compliant with ASX rules. The company continues to advance its flagship magnetite development in Western Australia, highlighting its alignment with green steel demand.

Stellar Resources has reported significant progress in its December quarter, advancing the Heemskirk Tin Project through robust drilling results and metallurgical studies, supported by a $9.5 million capital raise.

Argent BioPharma has signed a binding agreement to acquire AusCann’s 48% stake in CannPal, enhancing its clinical and intellectual property assets for CannEpil®. The deal includes an option for the Neuvis® drug-delivery platform and aligns with Argent’s U.S. dual-listing ambitions.

ECS Botanics reports a $218k positive operating cash flow in Q2 FY26, driven by strong B2C growth and new product launches. The company also secured $1.95 million in funding to fuel European expansion and product development.

The Calmer Co. International Limited has reported its highest ever monthly sales of $910,767 in December 2025, driven by strong wholesale growth and expanding US market presence.